MedCap AB (publ) - Laporan Laba Rugi (TTM)

MedCap AB (publ)
Laporan Laba Rugi (TTM)

Laporan Laba Rugi MedCap AB (publ) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 802 828 845 869 896 926 966 1,017 1,056 1,124 1,241 1,343 1,466 1,589 1,670 1,742 1,802 1,807 1,839 1,903
Change (%) 3.28 2.04 2.85 3.11 3.38 4.34 5.25 3.85 6.40 10.44 8.22 9.15 8.37 5.13 4.29 3.41 0.32 1.78 3.48
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 338 350 349 348 351 358 373 395 414 447 518 556 609 661 677 709 735 750 764 796
Change (%) 3.52 -0.40 -0.20 0.80 1.94 4.31 5.92 4.63 8.05 15.94 7.36 9.49 8.51 2.45 4.70 3.65 2.04 1.88 4.27
% of Revenue 42.20 42.29 41.28 40.06 39.16 38.62 38.60 38.85 39.14 39.75 41.73 41.39 41.53 41.58 40.52 40.68 40.78 41.48 41.52 41.84
Gross Operating Profit 463 478 496 521 545 569 593 622 643 677 723 787 857 928 994 1,033 1,067 1,058 1,076 1,107
Change (%) 3.11 3.83 5.00 4.65 4.31 4.36 4.82 3.36 5.34 6.82 8.83 8.90 8.27 7.03 4.01 3.24 -0.86 1.70 2.92
% of Revenue 57.80 57.71 58.72 59.94 60.84 61.38 61.40 61.15 60.86 60.25 58.27 58.61 58.47 58.42 59.48 59.32 59.22 58.52 58.48 58.16
SG&A 326 329 339 358 375 385 394 410 419 444 486 523 562 601 624 655 674 698 720 736
Change (%) 0.95 3.07 5.66 4.66 2.51 2.55 3.85 2.22 5.92 9.54 7.70 7.38 7.00 3.73 5.07 2.85 3.67 3.14 2.22
% of Revenue 40.68 39.76 40.16 41.25 41.88 41.52 40.81 40.27 39.63 39.46 39.13 38.95 38.31 37.83 37.32 37.60 37.40 38.65 39.16 38.69
R&D
Change (%)
% of Revenue
OpEx 737 755 766 784 804 822 848 892 923 975 1,096 1,174 1,272 1,373 1,411 1,477 1,524 1,566 1,609 1,663
Change (%) 2.41 1.40 2.36 2.63 2.26 3.12 5.15 3.51 5.60 12.44 7.05 8.41 7.91 2.80 4.66 3.19 2.77 2.72 3.37
% of Revenue 91.95 91.18 90.61 90.18 89.77 88.79 87.76 87.68 87.39 86.73 88.30 87.35 86.76 86.39 84.48 84.79 84.61 86.67 87.47 87.38
Operating Income 64 73 79 85 92 104 118 125 133 149 145 170 194 216 259 265 277 241 230 240
Change (%) 13.18 8.63 7.57 7.50 13.20 13.97 5.92 6.30 11.94 -2.62 17.01 14.24 11.39 19.89 2.24 4.64 -13.13 -4.36 4.25
% of Revenue 8.05 8.82 9.39 9.82 10.23 11.21 12.24 12.32 12.61 13.27 11.70 12.65 13.24 13.61 15.52 15.21 15.39 13.33 12.53 12.62
Interest Expense -5 -9 -10 -12 -13 -9 -10 -9 -10 -16 -18 -18 -19 -16 -15 -17 -15 -18 -19 -18
Change (%) 97.83 7.69 27.55 3.20 -27.13 9.57 -16.50 17.44 62.38 10.98 -1.65 5.59 -17.46 -1.92 13.07 -14.45 25.00 1.62 -2.13
% of Revenue -0.57 -1.10 -1.16 -1.44 -1.44 -1.01 -1.07 -0.85 -0.96 -1.46 -1.47 -1.33 -1.29 -0.98 -0.92 -0.99 -0.82 -1.02 -1.02 -0.97
Net Income 54 61 65 62 76 96 102 108 118 118 123 149 150 172 203 214 228 207 202 199
Change (%) 13.41 7.06 -5.06 22.78 26.97 5.80 5.29 9.67 -0.25 4.42 21.01 1.14 14.57 18.12 4.97 6.79 -9.04 -2.65 -1.63
% of Revenue 6.70 7.36 7.72 7.12 8.48 10.42 10.56 10.57 11.16 10.46 9.89 11.06 10.25 10.84 12.18 12.26 12.66 11.48 10.98 10.43

Source: Capital IQ

Other Listings
DE:61MA € 54.50
SE:MCAP SEK 618.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista